Molecular Probe
Showing 1 - 25 of 6,471
Breast Cancer Trial in Xiamen (ICG-SG incubation solution)
Recruiting
- Breast Cancer
- ICG-SG incubation solution
-
Xiamen, Fujian, ChinaXiamen Key Laboratory of Endocrine-Related Cancer Precision Medi
Jan 23, 2023
Prostate Cancer Trial in Xi'an (SPECT/CT imaging with 99mTc-P137 nuclide probe)
Not yet recruiting
- Prostate Cancer
- SPECT/CT imaging with 99mTc-P137 nuclide probe
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Jan 3, 2023
Solid Tumor Trial in Beijing (18F-DX600 PET/CT)
Recruiting
- Solid Tumor
- 18F-DX600 PET/CT
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jul 18, 2022
Fibroblast Activation Protein Inhibitor PET/CT Imaging in
Recruiting
- Gastrointestinal Cancer
- Fibroblast activation protein inhibitor PET/CT imaging
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 14, 2022
Abdominal Aortic Aneurysm (AAA) Trial in Saint Louis (Aortoiliac Occlusive Disease Group - PET-CT imaging with injection of
Terminated
- Abdominal Aortic Aneurysm (AAA)
- Aortoiliac Occlusive Disease Group - PET-CT imaging with injection of 64Cu-DOTA-ECL1i
- AAA Group- PET-CT imaging with injection of 64Cu-DOTA-ECL1i
-
Saint Louis, MissouriWashington University School of Medicine
Apr 9, 2022
Lymphoma Trial (68Ga-NOTA-RP25)
Not yet recruiting
- Lymphoma
- 68Ga-NOTA-RP25
- (no location specified)
Dec 16, 2021
Human Prostatic Disease
Active, not recruiting
- Prostate Cancer
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 24, 2021
Respiratory Infections Trial in Edinburgh (BAC TWO, FE and Cellvizio viewer software)
Completed
- Respiratory Infections
- BAC TWO
- FE and Cellvizio viewer software
-
Edinburgh, United KingdomRoyal Infirmary Edinburgh
Mar 24, 2020
Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou
Not yet recruiting
- Minimal Residual Disease
- Esophageal Squamous Cell Carcinoma
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Jun 10, 2023
Integrin avß6-targeted PET in Malignant Tumors
Recruiting
- Malignant Neoplasm
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Apr 18, 2023
Cardiac Amyloidosis Trial ([68Ga]CBP8 PET/MRI)
Not yet recruiting
- Cardiac Amyloidosis
- [68Ga]CBP8 PET/MRI
- (no location specified)
Nov 9, 2022
Shear-wave Elastography in Breast Cancer
Not yet recruiting
- Breast Cancer
- elastography
- (no location specified)
Nov 3, 2023
COVID-19 Pandemic Trial in United States (Diagnostic Test: IN Vitro)
Not yet recruiting
- COVID-19 Pandemic
- Diagnostic Test: IN Vitro
-
Miami, Florida
- +3 more
Jan 30, 2023
Neurodegenerative Disorders Trial in Fuzhou (18F-T807)
Recruiting
- Neurodegenerative Disorders
-
Fuzhou, Fujian, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Fuj
Nov 23, 2021
Lung Cancer Trial (Lung biopsy)
Not yet recruiting
- Lung Cancer
- Lung biopsy
- (no location specified)
May 25, 2022
Peripheral Pulmonary Nodules Trial in Shanghai (Linear Ultrasound Bronchoscope BF-UC290F (Olympus))
Recruiting
- Peripheral Pulmonary Nodules
- Linear Ultrasound Bronchoscope BF-UC290F (Olympus)
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Aug 21, 2022
Acute Lung Injury Trial in Edinburgh (Microdose of NAP)
Completed
- Acute Lung Injury
- Microdose of NAP
-
Edinburgh, Scotland, United Kingdom
- +2 more
Nov 1, 2019
Clinical Validation of Multimodal Digestive Endoscopy
Enrolling by invitation
- Rectal Neoplasms
- +3 more
-
Xi'an, Shaanxi, ChinaXijing Hospital
Oct 10, 2022
Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Tumor Trial in Wuhan (68Ga-FAPI, PET/CT)
Recruiting
- Fibroblast Activation Protein Inhibitor
- +2 more
- 68Ga-FAPI
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Aug 27, 2021
Barrett's Esophagus Without Dysplasia, Barrett Oesophagitis With Dysplasia, Esophageal Adenocarcinoma Trial in Groningen
Not yet recruiting
- Barrett's Esophagus Without Dysplasia
- +2 more
- Avastin
- +2 more
-
Groningen, NetherlandsUniversity Medical Center Groningen
Feb 24, 2023
Clinical Evaluation of tNGS for Diagnosis of DR-TB
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- targeted Next Generation Sequencing (tNGS)
-
Tbilisi, Georgia
- +2 more
Jan 23, 2023